How Moderna’s Cancer Breakthrough Reversed Its Fortunes and Revived the Stock
Yahoo Finance
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
The stock jumps after a melanoma treatment has success in a late-stage trial. One analyst says annual sales could hit $3 billion by 2035.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance